Gastritis epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
m (Bot: Removing from Primary care)
 
(35 intermediate revisions by 3 users not shown)
Line 3: Line 3:
{{CMG}}; {{AE}} {{ARK}}
{{CMG}}; {{AE}} {{ARK}}
==Overview==
==Overview==
In acute gastritis, the [[prevalence]] of [[eosinophilic]] gastritis is approximately 6.3 per 100,000 individuals worldwide. The [[incidence]] of new cases of ''[[H. pylori]]'' infection each year ranges from 3,000 to 10,000 per 100,000 individuals in developing countries. It has been observed that with advancing age, the [[incidence]] of ''[[H. pylori]]'' infection increases. In united states, 20% of adolescents are infected with [[H. pylori]] when compared to 90% by 5 years of age in developing countries. In United States, [[H. pylori|''H. pylori'']] infection associated gastritis is more common in African Americans (54%), Hispanics (52%), and the elderly compared to Whites (21%). In acute gastritis, females are usually more affected than men. In ''[[H. pylori]]'' infection associated gastritis, males are more commonly affected than females. The [[incidence]] rates of ''[[H. pylori]]'' infection are high in Japan, Columbia, Costa Rica and China, and comparatively low in the United States. [[H. pylori]] infection is common in Southern and Eastern Europe, Mexico, South America, Africa, most Asian countries, and aboriginal people in North America.


==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Incidence===
===Incidence===
 
*Chronic Gastritis:
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
**The [[incidence]] of new cases of [[H. pylori|''H. pylori'']] infection each year ranges from 3,000 to 10,000 per 100,000 individuals in developing countries. <ref name="pmid20124281">{{cite journal| author=Rosenberg JJ| title=Helicobacter pylori. | journal=Pediatr Rev | year= 2010 | volume= 31 | issue= 2 | pages= 85-6; discussion 86 | pmid=20124281 | doi=10.1542/pir.31-2-85 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20124281  }} </ref>
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
**The [[incidence]] of new cases of [[H. pylori|''H. pylori'']] infection each year is around 500 per 100,000 individuals in developed countries.<ref name="pmid20124281">{{cite journal| author=Rosenberg JJ| title=Helicobacter pylori. | journal=Pediatr Rev | year= 2010 | volume= 31 | issue= 2 | pages= 85-6; discussion 86 | pmid=20124281 | doi=10.1542/pir.31-2-85 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20124281  }} </ref>
 
*It has been observed that with advancing age, the incidence of [[H. pylori|''H. pylori'']] infection increases. <ref name="pmid2586553">{{cite journal| author=Dooley CP, Cohen H, Fitzgibbons PL, Bauer M, Appleman MD, Perez-Perez GI et al.| title=Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. | journal=N Engl J Med | year= 1989 | volume= 321 | issue= 23 | pages= 1562-6 | pmid=2586553 | doi=10.1056/NEJM198912073212302 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2586553  }} </ref>
*It has been observed that with advancing age, the incidence of H.pylori infection is increased.


===Prevalence===
===Prevalence===
*Acute Gastritis
*Acute Gastritis:
*The prevalence of eosinophilic gastritis is approximately 6.3 per 100,000 individuals worldwide <ref name="pmid25988554">{{cite journal| author=Jensen ET, Martin CF, Kappelman MD, Dellon ES| title=Prevalence of Eosinophilic Gastritis, Gastroenteritis, and Colitis: Estimates From a National Administrative Database. | journal=J Pediatr Gastroenterol Nutr | year= 2016 | volume= 62 | issue= 1 | pages= 36-42 | pmid=25988554 | doi=10.1097/MPG.0000000000000865 | pmc=4654708 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25988554  }} </ref>
**The prevalence of [[eosinophilic]] gastritis is approximately 6.3 per 100,000 individuals worldwide. <ref name="pmid25988554">{{cite journal| author=Jensen ET, Martin CF, Kappelman MD, Dellon ES| title=Prevalence of Eosinophilic Gastritis, Gastroenteritis, and Colitis: Estimates From a National Administrative Database. | journal=J Pediatr Gastroenterol Nutr | year= 2016 | volume= 62 | issue= 1 | pages= 36-42 | pmid=25988554 | doi=10.1097/MPG.0000000000000865 | pmc=4654708 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25988554  }} </ref>
 
===Case-fatality rate/Mortality rate===
*In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
*The case-fatality rate/mortality rate of [disease name] is approximately [number range].


===Age===
===Age===
*Acute Gastritis is observed in all age groups.
*[[H. pylori|''H. pylori'']] infection associated gastritis:
*Patients of all age groups may develop [disease name].
**All age groups may develop ''[[H. pylori]]'' infection.
*The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
**The [[prevalence]] of [[infection]] increases with age.<ref name="pmid2549098">{{cite journal| author=Mégraud F, Brassens-Rabbé MP, Denis F, Belbouri A, Hoa DQ| title=Seroepidemiology of Campylobacter pylori infection in various populations. | journal=J Clin Microbiol | year= 1989 | volume= 27 | issue= 8 | pages= 1870-3 | pmid=2549098 | doi= | pmc=267687 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2549098  }} </ref>
*[Disease name] commonly affects individuals younger than/older than [number of years] years of age.  
**About 30%-50% of [[H. pylori|''H. pylori'']] infections are acquired during childhood which increases to 90% during adulthood in developing countries.<ref name="pmid19298340">{{cite journal| author=Cheng H, Hu F, Zhang L, Yang G, Ma J, Hu J et al.| title=Prevalence of Helicobacter pylori infection and identification of risk factors in rural and urban Beijing, China. | journal=Helicobacter | year= 2009 | volume= 14 | issue= 2 | pages= 128-33 | pmid=19298340 | doi=10.1111/j.1523-5378.2009.00668.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19298340  }} </ref>
*[Chronic disease name] is usually first diagnosed among [age group].
**''[[H. pylori]]'' infection in developed countries is less common in children and reaches up to 60% with increasing age.<ref name="pmid11849122">{{cite journal| author=Go MF| title=Review article: natural history and epidemiology of Helicobacter pylori infection. | journal=Aliment Pharmacol Ther | year= 2002 | volume= 16 Suppl 1 | issue=  | pages= 3-15 | pmid=11849122 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11849122  }} </ref>
*[Acute disease name] commonly affects [age group].
**In United States, 20% of [[adolescents]] are infected with ''[[H. pylori]]'' when compared to 90% by 5 years of age in developing countries.<ref name="pmid12814771">{{cite journal| author=Frenck RW, Clemens J| title=Helicobacter in the developing world. | journal=Microbes Infect | year= 2003 | volume= 5 | issue= 8 | pages= 705-13 | pmid=12814771 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12814771  }} </ref>
**Children differ from adults with respect to ''[[H. pylori]]'' infection in terms of:<ref name="pmid18779740">{{cite journal| author=Elitsur Y, Dementieva Y, Rewalt M, Lawrence Z| title=Helicobacter pylori infection rate decreases in symptomatic children: a retrospective analysis of 13 years (1993-2005) from a gastroenterology clinic in West Virginia. | journal=J Clin Gastroenterol | year= 2009 | volume= 43 | issue= 2 | pages= 147-51 | pmid=18779740 | doi=10.1097/MCG.0b013e318157e4e7 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18779740  }} </ref><ref name="pmid21558964">{{cite journal| author=Koletzko S, Jones NL, Goodman KJ, Gold B, Rowland M, Cadranel S et al.| title=Evidence-based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children. | journal=J Pediatr Gastroenterol Nutr | year= 2011 | volume= 53 | issue= 2 | pages= 230-43 | pmid=21558964 | doi=10.1097/MPG.0b013e3182227e90 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21558964  }} </ref>
***[[Prevalence]] of [[infection]]
***High rate of [[antibiotic resistance]]
***The near-absence of [[Gastric malignancy|gastric malignancies]]
***Age specific problems with diagnostic tests and medications


===Race===
===Race===
*There is no racial predilection to [disease name].
*In United States, ''[[H. pylori]]'' infection associated gastritis is more common in African Americans (54%), Hispanics (52%), and the elderly compared to Whites (21%).<ref name="pmid10762567">{{cite journal| author=Everhart JE, Kruszon-Moran D, Perez-Perez GI, Tralka TS, McQuillan G| title=Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. | journal=J Infect Dis | year= 2000 | volume= 181 | issue= 4 | pages= 1359-63 | pmid=10762567 | doi=10.1086/315384 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10762567  }} </ref><ref name="EverhartKruszon‐Moran2000">{{cite journal|last1=Everhart|first1=James E.|last2=Kruszon‐Moran|first2=Deanna|last3=Perez‐Perez|first3=Guillermo I.|last4=Tralka|first4=Tommie Sue|last5=McQuillan|first5=Geraldine|title=Seroprevalence and Ethnic Differences inHelicobacter pyloriInfection among Adults in the United States|journal=The Journal of Infectious Diseases|volume=181|issue=4|year=2000|pages=1359–1363|issn=0022-1899|doi=10.1086/315384}}</ref>
*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
 
===Gender===
===Gender===
*In Acute Gastritis, women are usually more affected than men.
*In acute gastritis, females are usually more affected than men.
*In ''[[H. pylori]]'' infection associated gastritis, males are more commonly affected than females.<ref name="pmid17089189">{{cite journal |vauthors=de Martel C, Parsonnet J |title=Helicobacter pylori infection and gender: a meta-analysis of population-based prevalence surveys |journal=Dig. Dis. Sci. |volume=51 |issue=12 |pages=2292–301 |year=2006 |pmid=17089189 |doi=10.1007/s10620-006-9210-5 |url=}}</ref>


*[Disease name] affects men and women equally.
*[Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
===Region===
===Region===
*The majority of [disease name] cases are reported in [geographical region].
*[[H. pylori|''H. pylori'']] infection associated gastritis is common in Southern and Eastern Europe, Mexico, South America, Africa, most Asian countries, and aboriginal people in North America.<ref name="pmid18622470">{{cite journal| author=Kawakami E, Machado RS, Ogata SK, Langner M| title=Decrease in prevalence of Helicobacter pylori infection during a 10-year period in Brazilian children. | journal=Arq Gastroenterol | year= 2008 | volume= 45 | issue= 2 | pages= 147-51 | pmid=18622470 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18622470  }} </ref><ref name="pmid21896079">{{cite journal| author=Goh KL, Chan WK, Shiota S, Yamaoka Y| title=Epidemiology of Helicobacter pylori infection and public health implications. | journal=Helicobacter | year= 2011 | volume= 16 Suppl 1 | issue=  | pages= 1-9 | pmid=21896079 | doi=10.1111/j.1523-5378.2011.00874.x | pmc=3719046 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21896079  }} </ref>
 
*[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].


===Developed Countries===
===Developed Countries===
*The [[incidence]] of new cases of [[H. pylori|''H. pylori'']] infection each year is 0.5 percent in developed countries.<ref name="pmid20124281">{{cite journal| author=Rosenberg JJ| title=Helicobacter pylori. | journal=Pediatr Rev | year= 2010 | volume= 31 | issue= 2 | pages= 85-6; discussion 86 | pmid=20124281 | doi=10.1542/pir.31-2-85 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20124281  }} </ref>
*The [[prevalence]] of ''[[H. pylori]]'' is declining in the United States.
*In developed countries such as the United States, children acquire the [[H. pylori|''H. pylori'']] infection at a rate of about less than 1% per year.
*It is estimated that 30%-40% of the US population is infected with ''[[H. pylori]]''.<ref name="pmid11030073">{{cite journal| author=Everhart JE| title=Recent developments in the epidemiology of Helicobacter pylori. | journal=Gastroenterol Clin North Am | year= 2000 | volume= 29 | issue= 3 | pages= 559-78 | pmid=11030073 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11030073  }} </ref><ref name="pmid10809031">{{cite journal| author=Peterson WL, Fendrick AM, Cave DR, Peura DA, Garabedian-Ruffalo SM, Laine L| title=Helicobacter pylori-related disease: guidelines for testing and treatment. | journal=Arch Intern Med | year= 2000 | volume= 160 | issue= 9 | pages= 1285-91 | pmid=10809031 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10809031  }} </ref>
*In United States, approximately 25% of children between 6-19 years old are infected.<ref name="pmid8896521">{{cite journal |vauthors=Staat MA, Kruszon-Moran D, McQuillan GM, Kaslow RA |title=A population-based serologic survey of Helicobacter pylori infection in children and adolescents in the United States |journal=J. Infect. Dis. |volume=174 |issue=5 |pages=1120–3 |year=1996 |pmid=8896521 |doi= |url=}}</ref>
*The [[incidence]] rates of [[H. pylori|''H. pylori'']] infection are high in Japan, Columbia, Costa Rica and China, and comparatively low in the United States.


===Developing Countries===
===Developing Countries===
*In the developing countries, the prevalence of H. pylori infection is observed to be on a higher side when compared to developed nations.
*The [[prevalence]] of ''[[H. pylori]]'' is higher in developing countries than that in developed countries.<ref name="pmid19636185">{{cite journal| author=Salih BA| title=Helicobacter pylori infection in developing countries: the burden for how long? | journal=Saudi J Gastroenterol | year= 2009 | volume= 15 | issue= 3 | pages= 201-7 | pmid=19636185 | doi=10.4103/1319-3767.54743 | pmc=2841423 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19636185  }} </ref>
*The [[incidence]] of new cases of [[H.pylori]] infection each year ranges from 3,000 to 10,000 per 100,000 individuals in developing countries.<ref name="pmid20124281">{{cite journal| author=Rosenberg JJ| title=Helicobacter pylori. | journal=Pediatr Rev | year= 2010 | volume= 31 | issue= 2 | pages= 85-6; discussion 86 | pmid=20124281 | doi=10.1542/pir.31-2-85 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20124281  }} </ref>
*In the developing countries, children in the age group of 2 to 8 years acquire the [[H.pylori]] infection at a rate of about 10% per year.
*[[H. pylori|''H. pylori'']] infection is common in Southern and Eastern Europe, Mexico, South America, Africa, most Asian countries, and aboriginal people in North America.<ref name="pmid18622470">{{cite journal| author=Kawakami E, Machado RS, Ogata SK, Langner M| title=Decrease in prevalence of Helicobacter pylori infection during a 10-year period in Brazilian children. | journal=Arq Gastroenterol | year= 2008 | volume= 45 | issue= 2 | pages= 147-51 | pmid=18622470 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18622470  }} </ref><ref name="pmid21896079">{{cite journal| author=Goh KL, Chan WK, Shiota S, Yamaoka Y| title=Epidemiology of Helicobacter pylori infection and public health implications. | journal=Helicobacter | year= 2011 | volume= 16 Suppl 1 | issue=  | pages= 1-9 | pmid=21896079 | doi=10.1111/j.1523-5378.2011.00874.x | pmc=3719046 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21896079  }} </ref>
 
==Prevalence of Helicobacter pylori Infection Globally==
Prevalence of ''[[H. pylori]]'' infection globally<ref name="pmid21961099">{{cite journal| author=Hunt RH, Xiao SD, Megraud F, Leon-Barua R, Bazzoli F, van der Merwe S et al.| title=Helicobacter pylori in developing countries. World Gastroenterology Organisation Global Guideline. | journal=J Gastrointestin Liver Dis | year= 2011 | volume= 20 | issue= 3 | pages= 299-304 | pmid=21961099 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21961099  }} </ref>
 
{|
! colspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" + |'''Prevalence of Helicobacter pylori Infection Globally'''
|-
! colspan="2" rowspan="2" style="background:#4479BA; color: #FFFFFF;" + | Country
! colspan="2" style="background:#4479BA; color: #FFFFFF;" + | Prevalence per 100,000
|-
! style="background:#4479BA; color: #FFFFFF;" + | Children
! style="background:#4479BA; color: #FFFFFF;" + | Adult
|-
| rowspan="2" style="background:#DCDCDC; + " | '''Africa'''
| style="background:#F5F5F5; + " | Ethiopia
| style="background:#F5F5F5; + " | 48,000
| style="background:#F5F5F5; + " | >95,000
|-
| style="background:#F5F5F5; + " | Nigeria
| style="background:#F5F5F5; + " | 82,000
| style="background:#F5F5F5; + " | 91,000
|-
| rowspan="2" style="background:#DCDCDC; + " | '''Central America'''
| style="background:#F5F5F5; + " | Gautemala
| style="background:#F5F5F5; + " | 51,000
| style="background:#F5F5F5; + " | 65,000
|-
| style="background:#F5F5F5; + " | Mexico
| style="background:#F5F5F5; + " | 43,000
| style="background:#F5F5F5; + " | 90,000
|-
| rowspan="2" style="background:#DCDCDC; + " | '''North America'''
| style="background:#F5F5F5; + " | Canada
| style="background:#F5F5F5; + " | 7100
| style="background:#F5F5F5; + " | 23,000
|-
| style="background:#F5F5F5; + " | USA and Canada
| style="background:#F5F5F5; + " |
| style="background:#F5F5F5; + " | 30,000
|-
| rowspan="3" style="background:#DCDCDC; + " | '''South America'''
| style="background:#F5F5F5; + " | Bolivia
| style="background:#F5F5F5; + " | 54,000
| style="background:#F5F5F5; + " |
|-
| style="background:#F5F5F5; + " | Brazil
| style="background:#F5F5F5; + " | 30,000
| style="background:#F5F5F5; + " | 82,000
|-
| style="background:#F5F5F5; + " | Chile
| style="background:#F5F5F5; + " | 36,000
| style="background:#F5F5F5; + " | >70,000
|-
| rowspan="8" style="background:#DCDCDC; + " | '''Asia'''
| style="background:#F5F5F5; + " | Bangladesh
| style="background:#F5F5F5; + " | 60,000
| style="background:#F5F5F5; + " | >90,000
|-
| style="background:#F5F5F5; + " | Hong Kong
| style="background:#F5F5F5; + " | 13,000
| style="background:#F5F5F5; + " |
|-
| style="background:#F5F5F5; + " | India
| style="background:#F5F5F5; + " | 22,000
| style="background:#F5F5F5; + " | >80,000
|-
| style="background:#F5F5F5; + " | Japan
| style="background:#F5F5F5; + " |
| style="background:#F5F5F5; + " | >70,000
|-
| style="background:#F5F5F5; + " | Siberia
| style="background:#F5F5F5; + " | 30,000
| style="background:#F5F5F5; + " | 85,000
|-
| style="background:#F5F5F5; + " | South Korea
| style="background:#F5F5F5; + " | 56,000
| style="background:#F5F5F5; + " | 40,600
|-
| style="background:#F5F5F5; + " | Sri Lanka
| style="background:#F5F5F5; + " | 67,000
| style="background:#F5F5F5; + " | 72,000
|-
| style="background:#F5F5F5; + " | Taiwan
| style="background:#F5F5F5; + " | 11,000
| style="background:#F5F5F5; + " | >50,000
|-
| rowspan="1" style="background:#DCDCDC; + " | '''Australia'''
| style="background:#F5F5F5; + " | Australia
| style="background:#F5F5F5; + " |
| style="background:#F5F5F5; + " | 20,000
|-
| rowspan="11" style="background:#DCDCDC; + " | '''Europe'''
| style="background:#F5F5F5; + " | Eastern
| style="background:#F5F5F5; + " |
| style="background:#F5F5F5; + " | 70,000
|-
| style="background:#F5F5F5; + " | Albania
| style="background:#F5F5F5; + " |
| style="background:#F5F5F5; + " | 70700
|-
| style="background:#F5F5F5; + " | Bulgaria
| style="background:#F5F5F5; + " | 61,700
| style="background:#F5F5F5; + " |
|-
| style="background:#F5F5F5; + " | Czech Republic
| style="background:#F5F5F5; + " |
| style="background:#F5F5F5; + " | 42,000
|-
| style="background:#F5F5F5; + " | Estonia
| style="background:#F5F5F5; + " |
| style="background:#F5F5F5; + " | 60,000
|-
| style="background:#F5F5F5; + " | Germany
| style="background:#F5F5F5; + " |
| style="background:#F5F5F5; + " | 48,800
|-
| style="background:#F5F5F5; + " | Iceland
| style="background:#F5F5F5; + " |
| style="background:#F5F5F5; + " | 36,000
|-
| style="background:#F5F5F5; + " | Netherlands
| style="background:#F5F5F5; + " | 12000
| style="background:#F5F5F5; + " |
|-
| style="background:#F5F5F5; + " | Serbia
| style="background:#F5F5F5; + " | 36,400
| style="background:#F5F5F5; + " |
|-
| style="background:#F5F5F5; + " | Sweden
| style="background:#F5F5F5; + " |
| style="background:#F5F5F5; + " | 11,000
|-
| style="background:#F5F5F5; + " | Switzerland
| style="background:#F5F5F5; + " |
| style="background:#F5F5F5; + " | 11,900
|-
| rowspan="4" style="background:#DCDCDC; + " | '''Middle East'''
| style="background:#F5F5F5; + " | Egypt
| style="background:#F5F5F5; + " | 50,000
| style="background:#F5F5F5; + " | 90,000
|-
| style="background:#F5F5F5; + " | Libya
| style="background:#F5F5F5; + " | 50,000
| style="background:#F5F5F5; + " | 94,000
|-
| style="background:#F5F5F5; + " | Saudi Arabia
| style="background:#F5F5F5; + " | 40,000
| style="background:#F5F5F5; + " | 80,000
|-
| style="background:#F5F5F5; + " | Turkey
| style="background:#F5F5F5; + " | 64,000
| style="background:#F5F5F5; + " | 80,000
|}


==References==
==References==
Line 52: Line 212:
{{WS}}
{{WS}}


​​
[[Category:Medicine]]
[[Category:Gastroenterology]]
[[Category:Gastroenterology]]
[[Category:Up-To-Date]]

Latest revision as of 21:49, 29 July 2020

Gastritis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Gastritis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Diagnostic tests

Endoscopic tests
Nonendoscopic tests

X Ray

CT

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Gastritis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Gastritis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Gastritis epidemiology and demographics

CDC on Gastritis epidemiology and demographics

Gastritis epidemiology and demographics in the news

Blogs on Gastritis epidemiology and demographics

Directions to Hospitals Treating Gastritis

Risk calculators and risk factors for Gastritis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aravind Reddy Kothagadi M.B.B.S[2]

Overview

In acute gastritis, the prevalence of eosinophilic gastritis is approximately 6.3 per 100,000 individuals worldwide. The incidence of new cases of H. pylori infection each year ranges from 3,000 to 10,000 per 100,000 individuals in developing countries. It has been observed that with advancing age, the incidence of H. pylori infection increases. In united states, 20% of adolescents are infected with H. pylori when compared to 90% by 5 years of age in developing countries. In United States, H. pylori infection associated gastritis is more common in African Americans (54%), Hispanics (52%), and the elderly compared to Whites (21%). In acute gastritis, females are usually more affected than men. In H. pylori infection associated gastritis, males are more commonly affected than females. The incidence rates of H. pylori infection are high in Japan, Columbia, Costa Rica and China, and comparatively low in the United States. H. pylori infection is common in Southern and Eastern Europe, Mexico, South America, Africa, most Asian countries, and aboriginal people in North America.

Epidemiology and Demographics

Incidence

  • Chronic Gastritis:
    • The incidence of new cases of H. pylori infection each year ranges from 3,000 to 10,000 per 100,000 individuals in developing countries. [1]
    • The incidence of new cases of H. pylori infection each year is around 500 per 100,000 individuals in developed countries.[1]
  • It has been observed that with advancing age, the incidence of H. pylori infection increases. [2]

Prevalence

  • Acute Gastritis:
    • The prevalence of eosinophilic gastritis is approximately 6.3 per 100,000 individuals worldwide. [3]

Age

Race

  • In United States, H. pylori infection associated gastritis is more common in African Americans (54%), Hispanics (52%), and the elderly compared to Whites (21%).[10][11]

Gender

  • In acute gastritis, females are usually more affected than men.
  • In H. pylori infection associated gastritis, males are more commonly affected than females.[12]

Region

  • H. pylori infection associated gastritis is common in Southern and Eastern Europe, Mexico, South America, Africa, most Asian countries, and aboriginal people in North America.[13][14]

Developed Countries

  • The incidence of new cases of H. pylori infection each year is 0.5 percent in developed countries.[1]
  • The prevalence of H. pylori is declining in the United States.
  • In developed countries such as the United States, children acquire the H. pylori infection at a rate of about less than 1% per year.
  • It is estimated that 30%-40% of the US population is infected with H. pylori.[15][16]
  • In United States, approximately 25% of children between 6-19 years old are infected.[17]
  • The incidence rates of H. pylori infection are high in Japan, Columbia, Costa Rica and China, and comparatively low in the United States.

Developing Countries

  • The prevalence of H. pylori is higher in developing countries than that in developed countries.[18]
  • The incidence of new cases of H.pylori infection each year ranges from 3,000 to 10,000 per 100,000 individuals in developing countries.[1]
  • In the developing countries, children in the age group of 2 to 8 years acquire the H.pylori infection at a rate of about 10% per year.
  • H. pylori infection is common in Southern and Eastern Europe, Mexico, South America, Africa, most Asian countries, and aboriginal people in North America.[13][14]

Prevalence of Helicobacter pylori Infection Globally

Prevalence of H. pylori infection globally[19]

Prevalence of Helicobacter pylori Infection Globally
Country Prevalence per 100,000
Children Adult
Africa Ethiopia 48,000 >95,000
Nigeria 82,000 91,000
Central America Gautemala 51,000 65,000
Mexico 43,000 90,000
North America Canada 7100 23,000
USA and Canada 30,000
South America Bolivia 54,000
Brazil 30,000 82,000
Chile 36,000 >70,000
Asia Bangladesh 60,000 >90,000
Hong Kong 13,000
India 22,000 >80,000
Japan >70,000
Siberia 30,000 85,000
South Korea 56,000 40,600
Sri Lanka 67,000 72,000
Taiwan 11,000 >50,000
Australia Australia 20,000
Europe Eastern 70,000
Albania 70700
Bulgaria 61,700
Czech Republic 42,000
Estonia 60,000
Germany 48,800
Iceland 36,000
Netherlands 12000
Serbia 36,400
Sweden 11,000
Switzerland 11,900
Middle East Egypt 50,000 90,000
Libya 50,000 94,000
Saudi Arabia 40,000 80,000
Turkey 64,000 80,000

References

  1. ↑ 1.0 1.1 1.2 1.3 Rosenberg JJ (2010). "Helicobacter pylori". Pediatr Rev. 31 (2): 85–6, discussion 86. doi:10.1542/pir.31-2-85. PMID 20124281.
  2. ↑ Dooley CP, Cohen H, Fitzgibbons PL, Bauer M, Appleman MD, Perez-Perez GI; et al. (1989). "Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons". N Engl J Med. 321 (23): 1562–6. doi:10.1056/NEJM198912073212302. PMID 2586553.
  3. ↑ Jensen ET, Martin CF, Kappelman MD, Dellon ES (2016). "Prevalence of Eosinophilic Gastritis, Gastroenteritis, and Colitis: Estimates From a National Administrative Database". J Pediatr Gastroenterol Nutr. 62 (1): 36–42. doi:10.1097/MPG.0000000000000865. PMC 4654708. PMID 25988554.
  4. ↑ Mégraud F, Brassens-Rabbé MP, Denis F, Belbouri A, Hoa DQ (1989). "Seroepidemiology of Campylobacter pylori infection in various populations". J Clin Microbiol. 27 (8): 1870–3. PMC 267687. PMID 2549098.
  5. ↑ Cheng H, Hu F, Zhang L, Yang G, Ma J, Hu J; et al. (2009). "Prevalence of Helicobacter pylori infection and identification of risk factors in rural and urban Beijing, China". Helicobacter. 14 (2): 128–33. doi:10.1111/j.1523-5378.2009.00668.x. PMID 19298340.
  6. ↑ Go MF (2002). "Review article: natural history and epidemiology of Helicobacter pylori infection". Aliment Pharmacol Ther. 16 Suppl 1: 3–15. PMID 11849122.
  7. ↑ Frenck RW, Clemens J (2003). "Helicobacter in the developing world". Microbes Infect. 5 (8): 705–13. PMID 12814771.
  8. ↑ Elitsur Y, Dementieva Y, Rewalt M, Lawrence Z (2009). "Helicobacter pylori infection rate decreases in symptomatic children: a retrospective analysis of 13 years (1993-2005) from a gastroenterology clinic in West Virginia". J Clin Gastroenterol. 43 (2): 147–51. doi:10.1097/MCG.0b013e318157e4e7. PMID 18779740.
  9. ↑ Koletzko S, Jones NL, Goodman KJ, Gold B, Rowland M, Cadranel S; et al. (2011). "Evidence-based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children". J Pediatr Gastroenterol Nutr. 53 (2): 230–43. doi:10.1097/MPG.0b013e3182227e90. PMID 21558964.
  10. ↑ Everhart JE, Kruszon-Moran D, Perez-Perez GI, Tralka TS, McQuillan G (2000). "Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States". J Infect Dis. 181 (4): 1359–63. doi:10.1086/315384. PMID 10762567.
  11. ↑ Everhart, James E.; Kruszon‐Moran, Deanna; Perez‐Perez, Guillermo I.; Tralka, Tommie Sue; McQuillan, Geraldine (2000). "Seroprevalence and Ethnic Differences inHelicobacter pyloriInfection among Adults in the United States". The Journal of Infectious Diseases. 181 (4): 1359–1363. doi:10.1086/315384. ISSN 0022-1899.
  12. ↑ de Martel C, Parsonnet J (2006). "Helicobacter pylori infection and gender: a meta-analysis of population-based prevalence surveys". Dig. Dis. Sci. 51 (12): 2292–301. doi:10.1007/s10620-006-9210-5. PMID 17089189.
  13. ↑ 13.0 13.1 Kawakami E, Machado RS, Ogata SK, Langner M (2008). "Decrease in prevalence of Helicobacter pylori infection during a 10-year period in Brazilian children". Arq Gastroenterol. 45 (2): 147–51. PMID 18622470.
  14. ↑ 14.0 14.1 Goh KL, Chan WK, Shiota S, Yamaoka Y (2011). "Epidemiology of Helicobacter pylori infection and public health implications". Helicobacter. 16 Suppl 1: 1–9. doi:10.1111/j.1523-5378.2011.00874.x. PMC 3719046. PMID 21896079.
  15. ↑ Everhart JE (2000). "Recent developments in the epidemiology of Helicobacter pylori". Gastroenterol Clin North Am. 29 (3): 559–78. PMID 11030073.
  16. ↑ Peterson WL, Fendrick AM, Cave DR, Peura DA, Garabedian-Ruffalo SM, Laine L (2000). "Helicobacter pylori-related disease: guidelines for testing and treatment". Arch Intern Med. 160 (9): 1285–91. PMID 10809031.
  17. ↑ Staat MA, Kruszon-Moran D, McQuillan GM, Kaslow RA (1996). "A population-based serologic survey of Helicobacter pylori infection in children and adolescents in the United States". J. Infect. Dis. 174 (5): 1120–3. PMID 8896521.
  18. ↑ Salih BA (2009). "Helicobacter pylori infection in developing countries: the burden for how long?". Saudi J Gastroenterol. 15 (3): 201–7. doi:10.4103/1319-3767.54743. PMC 2841423. PMID 19636185.
  19. ↑ Hunt RH, Xiao SD, Megraud F, Leon-Barua R, Bazzoli F, van der Merwe S; et al. (2011). "Helicobacter pylori in developing countries. World Gastroenterology Organisation Global Guideline". J Gastrointestin Liver Dis. 20 (3): 299–304. PMID 21961099.

Template:WH Template:WS

​​

Retrieved from "https://www.wikidoc.org/index.php?title=Gastritis_epidemiology_and_demographics&oldid=1638401"